Program
Fluoride Toothpaste
Also written as “1.1% Fluoride toothpaste” and “0.243% Fluoride toothpaste”.
Its studies are mostly in Dental Caries, led by Colgate Palmolive.
Furthest: phase 3, since Dec 10, 20242 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmolive | 20 open or running | phase 3since Dec 10, 2024 | Mar 4, 2016 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 4, 2016First study: phase 2 study in Dental CariesFirst studyNCT02708160
- Dec 10, 2024Phase 3 study in Tooth DemineralizationNCT06732518 · 36 enrolled · Brazil
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06732518Tooth Demineralization · Brazil | 3 | Completed | Apr 24, 2025 | 36 |
| NCT02708160Dental Caries | 2 | Withdrawn | Jun 2016 | 0 |
How it is read
Names in the registry
- “Fluoride Toothpaste”, 1 entry
- “1.1% Fluoride toothpaste”, 1 entry
- “0.243% Fluoride toothpaste”, 1 entry
Conditions, from the studies’ own filings
- Dental Caries, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.